The Catalyst

Most Recent Posts


October 15 kicked off the 2013 Medicare Part D open enrollment period, which runs through December 7. During this time, Medicare-eligible Americans over 65 and persons with disabilities can choose a new Part D plan that best fits their needs.

10.31.12 | By John Castellani

Sandy is not over. The storm remains a serious, active threat to millions of Americans.


I've been lucky so far throughout Hurricane Sandy; save some spotty electricity, a branch threatening to smash my car and light flooding in my basement there has been no other damage.


We are very pleased to feature a guest blog post from Mary Woolley, President and CEO, Research!America, about support for medical innovation and why it is an important issue for the majority of likely voters during this year's election.


Below is a short Q&A that the Healthcare Leadership Council just posted on the Medicare Part D Open Enrollment process. Given our ongoing focus on Part D and helping seniors access resources to ensure a seamless experience, we are including the Q&A here:


[caption id="attachment_4244" align="alignleft" width="150" caption="Asad Zaidi/Courtesy of UNICEF Pakistan"][/caption]

10.23.12 | By Preet Bilinski

The third-leading cause of death in the U.S. is not nearly as recognizable as it should be, even to those who suffer from the condition.


I've been a contributor on our very own blog, the Catalyst, for a year now. I try my best to write interesting blog posts that pertain to the incredible work biopharmaceutical scientists do to help improve patient care in the U.S. and around the world.


At the heart of any productive relationship or venture is trust. In the biopharmaceutical sector, the integrity of our products, our research - and ultimately the faith that physicians and patients have in medicines - requires trust. And it's something that must be earned.

10.18.12 | By Chip Davis

I was encouraged Tuesday night during the Presidential debate to hear both candidates say they want to create high-wage, high-skill American jobs in what is called "advanced manufacturing." The biopharmaceutical industry represents just the kind of jobs the President wants and o

10.10.12 | By Preet Bilinski

Michael J. Fitzpatrick is executive director at NAMI, the National Alliance on Mental Illness.

10.09.12 | By Preet Bilinski

The stigma that surrounds mental illness remains a challenge. It can be difficult even for patients to accept and understand their diagnosis. So this week we join others in the mental health community participating in Mental Illness Awareness Week.


This morning, British scientist John Gurdon shared one of two Nobel Prizes awarded this year in physiology and medicine. Dr.


In this month's issue of Psychology Today, there was a good read about the psychological impact of having a rare disease, 'The Loneliest Fight', profiling four patients' experience with very differe


Medicare Today has released its 2012 beneficiary satisfaction survey results today and to put it simply, seniors love Medicare Part D.